Many neurological medications, including antidepressants, antipsychotics, and pain medications, are metabolized by CYP2D6. Variability in CYP2D6 activity can influence the efficacy and toxicity of these drugs. For instance, poor metabolizers may experience higher drug levels and increased side effects, while ultra-rapid metabolizers may have subtherapeutic drug levels.
